References
- MorseGDSheltonMJO’DonnellAMComparative pharmacokinetics of antiviral nucleoside analoguesClin Pharmacokinet19932421011238453821
- SmeeDFMartinJCVerheydenJPMatthewsTRAnti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl) guanineAntimicrob Agents Chemother19832356766826307132
- HollandGNBuhlesWCMastreBKaplanHA controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standard system for assessment of disease outcome. UCLA CMV Retinopathy Study GroupArch Ophthalmol198910712175917662556989
- Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitisN Engl J Med199232642132201345799
- YutthithamKRuamviboonsukPThe high-dose, alternate-week intra-vitreal ganciclovir injections for cytomegalovirus retinitis in acquired immune deficiency syndrome patients on highly active antiretroviral therapyJ Med Assoc Thai200588Suppl 9S63S6816681054
- AusayakhunSYuvavesPNgamtiphakomSPrasitsilpJTreatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovirJ Med Assoc Thai200588Suppl 9S15S2016681046
- ArevaloJFGarciaRAMendozaAJHigh-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in VenezuelaEur J Ophthalmol200515561061816167292
- MoschosMVamvasakisMKontogeorgosGPapantonisFPanagakisEChatzisVIntravitreal application of ganciclovir in rabbits: ERG and electron-microscopic findingsOphthalmologica199621042152228841069